SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-012577
Filing Date
2020-05-15
Accepted
2020-05-15 16:03:19
Documents
38
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0320_wizepharma.htm 10-Q 310948
2 CERTIFICATION f10q0320ex31-1_wizephar.htm EX-31.1 8223
3 CERTIFICATION f10q0320ex31-2_wizephar.htm EX-31.2 8092
4 CERTIFICATION f10q0320ex32-1_wizephar.htm EX-32.1 4845
5 CERTIFICATION f10q0320ex32-2_wizephar.htm EX-32.2 4808
  Complete submission text file 0001213900-20-012577.txt   1634386

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE wizp-20200331.xml EX-101.INS 234093
7 XBRL SCHEMA FILE wizp-20200331.xsd EX-101.SCH 29965
8 XBRL CALCULATION FILE wizp-20200331_cal.xml EX-101.CAL 28507
9 XBRL DEFINITION FILE wizp-20200331_def.xml EX-101.DEF 55781
10 XBRL LABEL FILE wizp-20200331_lab.xml EX-101.LAB 159841
11 XBRL PRESENTATION FILE wizp-20200331_pre.xml EX-101.PRE 108664
Mailing Address 24 HANAGAR ST HOD HASHARON L3 4527713
Business Address 24 HANAGAR ST HOD HASHARON L3 4527713 972 472 260 0536
Wize Pharma, Inc. (Filer) CIK: 0001218683 (see all company filings)

IRS No.: 880445167 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52545 | Film No.: 20884895
SIC: 2834 Pharmaceutical Preparations